Equities

Avant Brands Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Avant Brands Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.86
  • Today's Change0.01 / 1.18%
  • Shares traded21.27k
  • 1 Year change-28.93%
  • Beta1.4261
Data delayed at least 15 minutes, as of Mar 02 2026 15:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Avant Brands Inc. is a Canada-based cannabis company. The Company is a producer of handcrafted cannabis products. It has multiple operational production facilities across Canada, which produce handcrafted cannabis products based on cultivars. It offers a comprehensive product portfolio catering to recreational, medical, and export markets. Its consumer brands, including BLK MKT, Tenzo, Cognoscente, flowr and Treehugger, are available in recreational markets across Canada. Its products are distributed globally to Australia, Israel and Germany, with its flagship brand BLK MKT being sold in Israel. Additionally, its medical cannabis brand, GreenTec, serves qualified patients nationwide through its GreenTec Medical portal and medical cannabis partners. Treehugger provides premium eco-conscious craft cannabis. Its subsidiaries include 3PL Ventures Inc., Avant Craft Cannabis Inc., Avant K1 Brands Inc., GreenTec Bio-Pharmaceuticals Inc., and GreenTec Holdings Ltd., among others.

  • Revenue in CAD (TTM)37.49m
  • Net income in CAD-20.02m
  • Incorporated2017
  • Employees180.00
  • Location
    Avant Brands Inc1632 Dickson Avenue, Suite 335KELOWNA V1Y 7T2CanadaCAN
  • Phone+1 (778) 760-8338
  • Fax+1 (416) 915-4265
  • Websitehttps://avantbrands.ca/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.